Asthma Research Study

Asthma is usually characterized by chronic airway inflammation and symptoms of wheezing, shortness of breath, chest tightness and/or cough. Exercise, environmental/occupational exposures, and/or viral respiratory infections can trigger symptoms. The long-term goals of asthma management are to achieve good symptom control, minimize future risk of exacerbations, minimize fixed airflow limitation, and minimize side-effects of treatment.

People with non-eosinophilic asthma may be eligible to join this research study of an investigational medication for the condition. Eligible participants will receive compensation for study-related time, as well as study-related exams at no cost.

Eligible participants…

• Must be age 18 or older
• Must have poorly controlled asthma despite the use of an inhaled corticosteroid (ICS) and LABA for at least 3 months
• Must have had at least one asthma exacerbation in the past 12 months
• Must NOT have pulmonary disease other than asthma
• Must NOT smoke
• Will receive compensation for study-related time
• Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can talk to a Meridian enrollment specialist about this study by calling (402) 934-7563 (NE) or (912) 623-2240 (VA).